Nick Clarke

Nick Clarke has been in the pharmaceutical industry for over 21 years. Nick began their career in 1997 at Pfizer Pharmaceuticals, where they held the roles of Project Leader and Senior Director. In 2019, they joined NodThera as Chief Development Officer and SVP Preclinical & Translation. In their current role as VP Preclinical & Translational, they are leading the development of NodThera's lead candidate, NT-0167, through pre-IND testing.

Nick Clarke obtained a BSc Hons in Pharmacology from the University of Portsmouth between 1990 and 1994. Nick then went on to pursue a PhD in Anatomical Neuropharmacology at the University of Oxford between 1994 and 1997.